Literature DB >> 18757336

Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer.

Ingrid Kappers1, Houke M Klomp, Jacobus A Burgers, Nico Van Zandwijk, Rick L M Haas, Renée van Pel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18757336     DOI： 10.1200/JCO.2008.16.3709

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

Review 1.  Neoadjuvant and adjuvant epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer.

Authors:  Haoran Zhai; Wenzhao Zhong; Xuening Yang; Yi-Long Wu
Journal:  Transl Lung Cancer Res       Date:  2015-02

2.  Neoadjuvant erlotinib and surgical resection of a stage iiia papillary adenocarcinoma of the lung with an L861Q activating EGFR mutation.

Authors:  M Ong; K Kwan; S Kamel-Reid; M Vincent
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

3.  Surgical resection of lung adenocarcinoma after crizotinib treatment: report of a case.

Authors:  Kaoru Kaseda; Ken-ichi Watanabe; Keisuke Asakura; Akio Kazama
Journal:  World J Surg Oncol       Date:  2015-02-22       Impact factor: 2.754

4.  Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation status.

Authors:  Wenzhao Zhong; Xuening Yang; Honghong Yan; Xuchao Zhang; Jian Su; Zhihong Chen; Riqiang Liao; Qiang Nie; Song Dong; Qing Zhou; Jinji Yang; Haiyan Tu; Yi-Long Wu
Journal:  J Hematol Oncol       Date:  2015-05-17       Impact factor: 17.388

5.  Use of a tyrosine kinase inhibitor as neoadjuvant therapy for non-small cell lung cancer: A case report.

Authors:  A López-González; E Almagro; C Salas; A Varela; M Provencio
Journal:  Respir Med Case Rep       Date:  2013-04-24

Review 6.  Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review.

Authors:  Yoko Yamamoto; Ken Kodama; Tomohiro Maniwa; Masashi Takeda
Journal:  J Cardiothorac Surg       Date:  2017-11-23       Impact factor: 1.637

Review 7.  Resectable IIIA-N2 Non-Small-Cell Lung Cancer (NSCLC): In Search for the Proper Treatment.

Authors:  Debora Brascia; Giulia De Iaco; Marcella Schiavone; Teodora Panza; Francesca Signore; Alessandro Geronimo; Doroty Sampietro; Michele Montrone; Domenico Galetta; Giuseppe Marulli
Journal:  Cancers (Basel)       Date:  2020-07-25       Impact factor: 6.639

8.  Feasibility and Safety of Neoadjuvant Alectinib in Pulmonary Invasive Mucinous Adenocarcinoma with ALK Rearrangement: Case Report and Literature Review.

Authors:  Rumeng Gu; Ziling Shi; Ting Duan; Meijun Song
Journal:  Onco Targets Ther       Date:  2021-10-21       Impact factor: 4.147
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.